Sign Up to like & get recommendations! 0
Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2020.34045
Abstract: Key Points Question Is the accuracy of magnetic resonance imaging (MRI)–guided biopsy comparable with reference-standard surgical resection for diagnosing pathologic complete response after neoadjuvant chemotherapy in patients with breast cancer? Findings In this pilot nonrandomized… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2020.2535
Abstract: Importance Pathologic complete response (pCR) is a known prognostic biomarker for long-term outcomes. The I-SPY2 trial evaluated if the strength of this clinical association persists in the context of a phase 2 neoadjuvant platform trial.… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Cancer"
DOI: 10.1002/cncr.32830
Abstract: The objective of this study was to determine an axillary pathologic complete response (pCR) and its influencing factors in patients with hormone receptor (HR)–positive breast cancer and cytologically proven axillary lymph node metastases. A prediction… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.27103
Abstract: The aim of this study was to analyze factors associated with pathologic complete response (pCR) following neoadjuvant chemoradiation (NCRT) and esophagectomy for carcinoma of the esophagus (EC) and gastroesophageal junction (GEJ). read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "European Radiology"
DOI: 10.1007/s00330-019-06513-0
Abstract: Objective This study was conducted in order to determine the optimal timing of diffusion-weighted magnetic resonance imaging (DW-MRI) for prediction of pathologic complete response (pCR) to neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer. Methods Patients with… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Clinical and Translational Radiation Oncology"
DOI: 10.1016/j.ctro.2017.04.004
Abstract: Highlights • A large population based analysis to evaluate pathologic response according to time of surgery.• LARC patients were treated with modern techniques of radiotherapy and surgery.• The rate of pCR increased according to time… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2022.02.006
Abstract: OBJECTIVE To determine the clinical characteristics of patients who attained pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT) and to identify specific predictive or prognostic factors associated with pCR. METHODS Two distinct populations of patients… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "British Journal of Cancer"
DOI: 10.1038/bjc.2017.61
Abstract: Reply to ‘Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy’’ read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Modern Pathology"
DOI: 10.1038/modpathol.2017.41
Abstract: Magee Equations were derived as an inexpensive, rapid alternative to Oncotype DX. The Magee Equation 3 utilizes immunohistochemical and FISH data for estrogen receptor (ER), progesterone receptor (PR), HER2 and Ki-67 for its calculation (24.30812+ERIHC… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Seminars in thoracic and cardiovascular surgery"
DOI: 10.1053/j.semtcvs.2021.10.016
Abstract: Diabetes is a common comorbidity in the U.S. and is associated with adverse outcomes in a variety of disease processes. Other cancer specialties have shown an association of diabetes with poor oncologic outcomes. We hypothesized… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000011647
Abstract: Abstract Lymphovascular invasion (LVI) has been a predictor of worse survival outcomes in breast cancer. However, the role of LVI compared than pathologic complete response (pCR) following neoadjuvant chemotherapy (NAC) remains unclear. The aim of… read more here.